BPIA applauds last week’s announcement from the USDA in collaboration with HHS launching a $700 million Regenerative Pilot Program.
BPIA applauds last week’s announcement from the USDA in collaboration with HHS launching a $700 million Regenerative Pilot Program.
Please join us at the historic Capital Hilton in Washington, D.C., on March 4-6, 2026, for the BPIA 2026 Annual Meeting. Don’t miss the most important annual gathering for the biological products industry in North America.
BPIA joined a coalition of industry associations in sending a letter to Congressional leadership urging swift, bipartisan passage of the Fiscal Year 2026 Interior, Environment, and Related Agencies appropriations bill.
The Biological Products Industry Alliance (BPIA) promotes the responsible development of safe and effective biological products including biopesticides, biostimulants, and biofertilizers as beneficial tools for commercial agriculture, forestry, golf courses, home gardens, horticulture, ornamentals, public health, and more through education, outreach, and advocacy activities at the state, federal, and international levels. Our members provide solutions that benefit growers, consumers, and the environment.